Markets·October 24, 2026 at 10:06 AM EDT·2 sources
Wells Fargo, Cisco, Marvell among latest firms objecting to OKXICE's tokenized stock plan
MRNA -1.2%INTU
MRNA · last 30 trading days-1.2% since the news
News
What happened
- Six more companies have objected to listing tokenized versions of their stock on the planned OKX-ICE venue, Reuters reported.
- The additions include Wells Fargo, Cisco, Marvell, Arm, Moderna and Intuit.
- The total number of companies objecting has reached 22.
Companies objecting
22
New objections
Six
Why it matters
The objections could affect the planned tokenized-stock venue and are relevant to markets and capital-markets professionals assessing issuer participation and platform viability.
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
Timeline
- EarlierOct 23Tango combo clears Rasonque bar, Takeda's Innovent bet gets early returns, plus more from #ESMO26
- EarlierOct 23The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- EarlierYesterdayModerna Investors Should Brace for More Whiplash
- EarlierYesterdayCancer vaccine data from #ESMO26; Treasury proposal could curb China investment; and more
- First reported by CoinDeskYesterdayWells Fargo, Cisco, Marvell among latest firms objecting to OKXICE's tokenized stock plan
- Decrypt reports6hWells Fargo, Cisco, Intuit Among 6 More Companies Objecting to Tokenized Stocks
Who is involved
Wells Fargo, Cisco, Marvell among latest firms objecting to O…OKX-ICEWells FargoCiscoMarvellArmModernaMRNAIntuitINTU
Company
Sources (2)
Related
- Oct 21 · Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
- Yesterday · STAT+: The ESMO presentation everyone’s been waiting for
- Yesterday · Cancer vaccine data from #ESMO26; Treasury proposal could curb China investment; and more
- Yesterday · Moderna Investors Should Brace for More Whiplash
- Oct 23 · The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- Oct 23 · Tango combo clears Rasonque bar, Takeda's Innovent bet gets early returns, plus more from #ESMO26
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
- Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
- Follow developing storiesAn alert, and a push, the moment a story you follow moves.
- Your briefing, read aloudA few minutes each morning with a chapter per story.
- Brief modeSwipe through the day, a 20-second card each.